BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
  • Homepage
  • Online Submission
Number of total visits
3546281
Number of visits today
5137
Number of downloads
2724739
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Xiao C, Rossignol F, Vaz FM, Ferreira CR. Inherited disorders of complex lipid metabolism: A clinical review. J Inherit Metab Dis 2021;44:809-25. [PMID: 33594685 DOI: 10.1002/jimd.12369] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Dubland JA. Lipid analysis by ion mobility spectrometry combined with mass spectrometry: A brief update with a perspective on applications in the clinical laboratory. J Mass Spectrom Adv Clin Lab 2022;23:7-13. [PMID: 34988541 DOI: 10.1016/j.jmsacl.2021.12.005] [Reference Citation Analysis]
2 Zhao H, Liu M, Lv Y, Fang M. Dose-response metabolomics and pathway sensitivity to map molecular cartography of bisphenol A exposure. Environ Int 2021;158:106893. [PMID: 34592654 DOI: 10.1016/j.envint.2021.106893] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
3 Boldyreva LV, Morozova MV, Saydakova SS, Kozhevnikova EN. Fat of the Gut: Epithelial Phospholipids in Inflammatory Bowel Diseases. Int J Mol Sci 2021;22:11682. [PMID: 34769112 DOI: 10.3390/ijms222111682] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
4 Natesan V, Kim SJ. Lipid Metabolism, Disorders and Therapeutic Drugs - Review. Biomol Ther (Seoul) 2021;29:596-604. [PMID: 34697272 DOI: 10.4062/biomolther.2021.122] [Reference Citation Analysis]
5 Ferreira CR, Martinelli D, Blau N. Clinical and biochemical footprints of inherited metabolic diseases. VI. Metabolic dermatoses. Mol Genet Metab 2021:S1096-7192(21)00756-3. [PMID: 34304991 DOI: 10.1016/j.ymgme.2021.07.005] [Reference Citation Analysis]
6 Brial F, Hedjazi L, Sonomura K, Al Hageh C, Zalloua P, Matsuda F, Gauguier D. Genetic Architecture of Untargeted Lipidomics in Cardiometabolic-Disease Patients Combines Strong Polygenic Control and Pleiotropy. Metabolites 2022;12:596. [DOI: 10.3390/metabo12070596] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2022 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345